| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |